4.16
2.35%
-0.10
Handel nachbörslich:
4.20
0.04
+0.96%
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
1.00M%
10.01
|
-0.001 | 25.20 | 0.119 | 0.226 |
Operating Expenses |
8.87%
100.37
|
92.19 | 98.78 | 106.17 | 101.40 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
8.87%
100.37
|
92.19 | 98.78 | 106.17 | 101.40 |
Operating Income/Loss |
1.99%
-90.36
|
-92.20 | -73.58 | -106.05 | -101.18 |
Income/Loss From Continuing Operations Before Tax |
1.00M%
10.01
|
-0.001 | 25.20 | -98.50 | -94.24 |
Income/Loss From Continuing Operations After Tax |
2.52%
-81.39
|
-83.50 | -65.73 | -98.50 | -94.24 |
Net Income/Loss
|
2.52%
-81.39
|
-83.50 | -65.73 | -98.50 | -94.24 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
17,740%
130.84
|
0.7334 | 122.23 | 121.68 | 121.32 |
Basic Earnings Per Share |
7.46%
-0.62
|
-0.67 | -0.54 | -0.81 | -0.78 |
Diluted Earnings Per Share |
7.46%
-0.62
|
-0.67 | -0.54 | -0.81 | -0.78 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):